A new international study led by Prof. Carmit Levy of the Department of Human Genetics and Biochemistry at the Gray Faculty ...
Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
Could this common symptom be a sign of pancreatic cancer? - Abdominal pain or back pain could be symptoms of the UK’s fifth ...
Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...
The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...
Researchers reveal ELI-002 2P cancer vaccine shows promise in boosting immune responses for colorectal and pancreatic cancer ...
In 2021, at just 3 years old, Connor Whaley was diagnosed with b-cell leukemia. In 2024, he relapsed, and is continuing to ...
Patient-centered care in MM involves aligning treatment with evolving quality-of-life priorities, especially during remission.
Final results from the phase 3 CASSANDRA trial presented at the 2025 ASCO Meeting show that the neoadjuvant chemotherapy ...
Maintaining CDK4/6 inhibition constrains drug‑resistant breast tumors by delaying cell‑cycle entry, and adding CDK2 inhibition further deepens control to guide post‑progression therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback